Since the anthrax attacks in 2001, some $60 billion has been spent on biodefence in the United States. But the money has not bought quite what was hoped.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional information
See Comment page 153
Erika Check Hayden is a senior reporter for Nature in San Francisco, California.
Related links
Rights and permissions
About this article
Cite this article
Check Hayden, E. Biodefence since 9/11: The price of protection. Nature 477, 150–152 (2011). https://doi.org/10.1038/477150a
Published:
Issue Date:
DOI: https://doi.org/10.1038/477150a
This article is cited by
-
Vaccine research loses out
Nature (2011)
